Abstract
Background
Sivelestat, a selective inhibitor of neutrophil elastase, has been reported to reduce acute lung injury associated with systemic inflammatory response syndrome (SIRS). However, no study has addressed the effect of prophylactic sivelestat administration on the postoperative course following an esophagectomy in older patients.
Methods
In this retrospective study of patients aged >70 years, we performed a propensity score-matched analysis to compare short and long-term outcomes between patients who received early postoperative sivelestat administration (n = 42) and those who did not receive sivelestat (controls; n = 42) after a transthoracic esophagectomy for esophageal cancer (EC).
Results
Patient backgrounds were well balanced between the two groups. The sivelestat group showed significantly shorter SIRS durations compared to the control group (2 vs 5 days, p = 0.001). In addition, postoperative hospital stays were shorter in the sivelestat group than in the control group (26 vs 31 days, p = 0.013). Other factors did not differ between the two groups, including the reoperation rate, ICU stay, duration of mechanical ventilation, and duration of O2 supply. Postoperatively, the sivelestat group showed significantly lower heart rates than the control group (repeated-measures ANOVA, p = 0.0389) while respiratory rates, the SpO2 levels, and body temperatures did not significantly differ between the two groups. Finally, long-term survival appeared to be not different between the two groups.
Conclusions
Sivelestat effectively stabilized postoperative vital signs and shortened SIRS durations. Thus, prophylactic sivelestat led to shorter hospital stays among older patients with EC who underwent an esophagectomy.
Similar content being viewed by others
Abbreviations
- CT:
-
Computed tomography
- EC:
-
Esophageal cancer
- FDG-PET:
-
18F-fluorodeoxyglucose-positron emission tomography
- LN:
-
Lymph node
- SIRS:
-
Systemic inflammatory response syndrome
References
Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232(2):225–32.
Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78(4):1170–6.
Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236(2):184–90.
Razavi HM, le Wang F, Weicker S, et al. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med. 2004;170(3):227–33.
Nishiyama J, Matsuda M, Ando S, et al. The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer. Surg Today. 2012;42(7):659–65.
Tanaka H, Sugimoto H, Yoshioka T, et al. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. Ann Surg. 1991;213(1):81–5.
Petty TL. Protease mechanisms in the pathogenesis of acute lung injury. Ann N Y Acad Sci. 1991;624:267–77.
Yang HX, Ling L, Zhang X, et al. Outcome of elderly patients with oesophageal squamous cell carcinoma after surgery. Br J Surg. 2010;97(6):862–7.
Guo L, Yamaguchi Y, Ikei S, et al. Neutrophil elastase inhibitor (ONO-5046) prevents lung hemorrhage induced by lipopolysaccharide in rat model of cerulein pancreatitis. Dig Dis Sci. 1995;40(10):2177–83.
Matsuzaki K, Hiramatsu Y, Homma S, et al. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg. 2005;80(2):611–7.
Tamakuma S, Ogawa M, Aikawa N, et al. Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther. 2004;17(5):271–9.
Nagai Y, Watanabe M, Baba Y, et al. Preventive effect of sivelestat on postoperative respiratory disorders after thoracic esophagectomy. Surg Today. 2013;43(4):361–6.
Mimatsu K, Oida T, Kawasaki A, et al. Influence of neutrophil elastase inhibitor on the postoperative course in patients with esophageal cancer after transthoracic esophagectomy. Hepatogastroenterology. 2011;58(110–111):1583–7.
Makino H, Kunisaki C, Kosaka T, et al. Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Br J Surg. 2011;98(7):975–82.
Iwahashi M, Nakamori M, Nakamura M, et al. Optimal period for the prophylactic administration of neutrophil elastase inhibitor for patients with esophageal cancer undergoing esophagectomy. World J Surg. 2011;35(7):1573–9.
Kawahara Y, Ninomiya I, Fujimura T, et al. Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23(4):329–39.
Suda K, Kitagawa Y, Ozawa S, et al. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20(6):478–86.
Ono S, Tsujimoto H, Hiraki S, et al. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007;31(10):1996–2001.
Yamaguchi K, Sugasawa Y, Takeuchi K, et al. Effects of sivelestat on bronchial inflammatory responses after esophagectomy. Int J Mol Med. 2011;28(2):187–92.
Sobin LGM, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley; 2009.
Rosenbaum PR, Rubin D. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–8.
Jr DAR. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.
Makino T, Yamasaki M, Miyata H, et al. Solitary lymph node recurrence of esophageal squamous cell carcinoma: surgical failure or systemic disease? Ann Surg Oncol. 2016;23(6):2087–93.
Makino T, Yamasaki M, Miyazaki Y, et al. Short and long-term outcomes of larynx-preserving surgery for cervical esophageal cancer: analysis of 100 consecutive cases. Ann Surg Oncol. 2016;23(5):858–65.
Yamashita K, Makino T, Miyata H, et al. Postoperative infectious complications are associated with adverse oncologic outcomes in esophageal cancer patients undergoing preoperative chemotherapy. Ann Surg Oncol. 2016;23(6):2106–14.
Qiu D, Kaneko S. Comparison of esophageal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960–2000). Jpn J Clin Oncol. 2005;35(9):564–7.
Shimada H, Shiratori T, Okazumi S, et al. Surgical outcome of elderly patients 75 years of age and older with thoracic esophageal carcinoma. World J Surg. 2007;31(4):773–9.
Tsukada K, Miyazaki T, Katoh H, et al. Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. Dig Liver Dis. 2006;38(4):240–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.
Conflict of interest
There are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Makino, T., Yamasaki, M., Tanaka, K. et al. The impact of prophylactic administration of a neutrophil elastase inhibitor on the postoperative course in older patients undergoing esophagectomy for esophageal cancer: a propensity score-matched analysis. Esophagus 14, 241–248 (2017). https://doi.org/10.1007/s10388-017-0571-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-017-0571-y